Zobrazeno 1 - 10
of 77
pro vyhledávání: '"Ali Uğur Ural"'
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 3, Pp 231-238 (2014)
OBJECTIVE: Deregulation of the cell cycle and apoptosis mechanisms in normal cells causes many problems, including cancer. In this study, a genome-wide expression analysis of cell cycle- and apoptosis-related genes in corticosteroid-, vincristine-, a
Externí odkaz:
https://doaj.org/article/baf796c424a4440a97f1a239be4a2477
Optimization of transfection of green fluorescent protein in pursuing mesenchymal stem cells in vivo
Publikováno v:
Turkish Journal of Hematology, Vol 25, Iss 04, Pp 172-175 (2008)
OBJECTIVE: Green Fluorescent Protein (GFP) has been used as a marker of gene expression and a single cell marker in living organisms in cell biology studies. The important areas that GFP is used are expression levels of different genes in different o
Externí odkaz:
https://doaj.org/article/93f6b6e1ccd646839a3d313b3c6cd5bf
Autor:
Ö. Pişkin, Fahri Şahin, Yusuf Baran, Güray Saydam, Melis Kartal Yandim, Mehmet Özcan, Ilknur Kozanoglu, Ferit Avcu, Ali Ünal, Hakan Ozdogu, Ali Uğur Ural
Publikováno v:
Journal of Hematology and Therapeutics. 2:1-7
Autor:
Meltem Ayli, Selim Sayın, Ferit Avcu, Melda Cömert, Murat Yıldırım, Elif Şafak Yılmaz, Bilge Uğur, Ali Uğur Ural
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S288-S289
Context: There is still no clear information about the incidence and consequences of infections with cyclophosphamide (PTCy) administration as prophylaxis against graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantati
Autor:
Esra Şafak Yılmaz, Ferit Avcu, Melda Cömert, Selim Sayın, Ali Uğur Ural, Murat Yıldırım, Meltem Ayli
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S288
Context: The ideal prophylaxis regimen for graft versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) from an unrelated donor has not yet determined clearly. Comparative studies on anti-thymocyte globulin (A
Autor:
Murat Yıldırım, Selim Sayın, Melda Cömert, Esra Şafak Yılmaz, Ferit Avcu, Ali Uğur Ural, Meltem Aylı
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S212
Autor:
Selim Sayın, Murat Yıldırım, Melda Cömert, Bilge Ugur, Elif Şafak Yılmaz, Ferit Avcu, Ali Uğur Ural, Meltem Aylı
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 21:S213
Autor:
Sinem Civriz Bozdag, Osman Ilhan, Irfan Yavasoglu, Huseyin Saffet Bekoz, Zafer Gulbas, Ali Uğur Ural, Ant Uzay, Guldane Cengiz Seval, Meltem Aylı, Omur Gokmen Sevindik, Emin Kaya, Meltem Kurt Yuksel, Burak Deveci, Zubeyde Nur Ozturk
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S191
Introduction: Despite major improvements in allogeneic hematopoetic stem cell transplantation form matched related/ unrelated donor over last decades, chronic graft-versus-host disease (cGVHD) is still the leading cause of late treatmentrelated death
Autor:
Ferit Avcu, Erhan Astarci, Salim Ozenc, Rahşan Ilikçi Sağkan, Meral Sarper, Ali Uğur Ural, Önder Öngörü, Mualla Pınar Elçi, Ozgur Koru, Tayfun Ide, Cengizhan Acikel, Duran Tok, Ertan Altayli
Publikováno v:
Volume: 45, Issue: 1 38-46
Turkish Journal of Medical Sciences
Turkish Journal of Medical Sciences
In this study, the in vitro and in vivo effectiveness of caffeic acid (3,4-dihydroxycinnamic acid) phenethyl ester (CAPE) in combination with bortezomib, a proteasome inhibitor, was explored in multiple myeloma (MM) cells. Materials and methods: The